Home / Risperidone / Canada
CA ATC N05AX08 · updated 2 Nov 2026
Risperidone shortage in Canada
Is there a Risperidone shortage in Canada?
Yes. As of 2 Nov 2026, 23 Risperidone products are reported short in Canada, the first since 17 May 2017. The company estimate for the return is 15 Dec 2026 (latest 1 Jun 2027). Main reason: manufacturing problem.
Also short in Germany, France, Italy, Spain, Ireland, Austria, Belgium, Czechia, Sweden, Japan, New Zealand, Australia. All countries.
Affected products in Canada
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CA | ACT RISPERIDONE (60) | ACTAVIS PHARMA COMPANY | 17 May 2017 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | MAR-RISPERIDONE (100 Tablet) | MARCAN PHARMACEUTICALS INC | 16 Feb 2021 | not given | Other Other (Please describe in comments) |
| CA | MAR-RISPERIDONE (100 Tablet) | MARCAN PHARMACEUTICALS INC | 16 Feb 2021 | not given | Other Other (Please describe in comments) |
| CA | MAR-RISPERIDONE (100 Tablet) | MARCAN PHARMACEUTICALS INC | 16 Feb 2021 | not given | Other Other (Please describe in comments) |
| CA | TARO-RISPERIDONE (100's) | SUN PHARMA CANADA INC | 14 Feb 2024 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | TARO-RISPERIDONE (100's Bottle) | SUN PHARMA CANADA INC | 1 Mar 2024 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | TARO-RISPERIDONE (60's) | SUN PHARMA CANADA INC | 1 Sep 2024 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | TARO-RISPERIDONE (60's) | SUN PHARMA CANADA INC | 1 Sep 2024 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | TARO-RISPERIDONE (60's) | SUN PHARMA CANADA INC | 1 Sep 2024 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | RISPERIDONE (100) | SIVEM PHARMACEUTICALS ULC | 2 Jul 2025 | 1 Jun 2027 | Manufacturing problem Disruption of the manufacture of the drug |
| CA | RISPERIDONE (500) | SIVEM PHARMACEUTICALS ULC | 2 Jul 2025 | 1 Jun 2027 | Manufacturing problem Disruption of the manufacture of the drug |
| CA | RISPERIDONE (500) | SIVEM PHARMACEUTICALS ULC | 14 Jul 2025 | 1 Jun 2027 | Manufacturing problem Disruption of the manufacture of the drug |
| CA | RISPERIDONE (100) | SIVEM PHARMACEUTICALS ULC | 11 Aug 2025 | 1 Jun 2027 | Manufacturing problem Disruption of the manufacture of the drug |
| CA | TARO-RISPERIDONE (60's) | SUN PHARMA CANADA INC | 1 Sep 2025 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | JAMP-RISPERIDONE (30) | JAMP PHARMA CORPORATION | 31 Oct 2025 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | RISPERIDONE (100) | SIVEM PHARMACEUTICALS ULC | 1 May 2026 | 1 Jun 2027 | Manufacturing problem Disruption of the manufacture of the drug |
| CA | RISPERIDONE (100) | SIVEM PHARMACEUTICALS ULC | 1 May 2026 | 1 Jun 2027 | Manufacturing problem Disruption of the manufacture of the drug |
| CA | APO-RISPERIDONE (30 ml) discontinuation | APOTEX INC | not given | not given | Not stated |
| CA | APO-RISPERIDONE (30 ml) discontinuation | APOTEX INC | not given | not given | Not stated |
| CA | RISPERDAL ORAL SOLUTION (1) discontinuation | JANSSEN INC | not given | not given | Not stated |
| CA | TARO-RISPERIDONE (60s) discontinuation | SUN PHARMA CANADA INC | not given | 15 Dec 2026 | Not stated |
| CA | TARO-RISPERIDONE (60s) discontinuation | SUN PHARMA CANADA INC | not given | 15 Dec 2026 | Not stated |
| CA | TARO-RISPERIDONE (60s) discontinuation | SUN PHARMA CANADA INC | not given | not given | Not stated |
Source
Health Canada, Health Product Shortages Canada. Official list. Mandatory company reports since 2017: actual and anticipated shortages, plus products about to be discontinued.